Equities

Camlin Fine Sciences Ltd

CAMLINFINE:NSI

Camlin Fine Sciences Ltd

Actions
Basic MaterialsChemicals
  • Price (INR)106.20
  • Today's Change1.25 / 1.19%
  • Shares traded421.08k
  • 1 Year change-36.00%
  • Beta1.6397
Data delayed at least 15 minutes, as of Sep 20 2024 11:28 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments8129521,288
Total Receivables, Net3,6563,9373,537
Total Inventory5,2625,7453,797
Prepaid expenses8311489
Other current assets, total194130224
Total current assets10,00710,8788,935
Property, plant & equipment, net8,0238,3447,403
Goodwill, net471528528
Intangibles, net128134232
Long term investments79246249
Note receivable - long term4842147
Other long term assets137----
Total assets19,51720,60118,001
LIABILITIES
Accounts payable3,2462,8842,338
Accrued expenses9606.90
Notes payable/short-term debt2,3353,7152,350
Current portion long-term debt/capital leases9976660
Other current liabilities, total6491,2651,198
Total current liabilities7,3237,9305,953
Total long term debt3,4994,2244,047
Total debt6,8308,0056,456
Deferred income tax68151103
Minority interest(78)47171
Other liabilities, total5855248
Total liabilities10,87012,40710,521
SHAREHOLDERS EQUITY
Common stock167157157
Additional paid-in capital4,9023,8273,819
Retained earnings (accumulated deficit)2,5963,2232,538
Treasury stock - common------
Unrealized gain (loss)449638826
Other equity, total533348140
Total equity8,6488,1947,479
Total liabilities & shareholders' equity19,51720,60118,001
Total common shares outstanding167157157
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.